Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
about
Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.
P2860
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
@ast
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
@en
type
label
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
@ast
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
@en
prefLabel
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
@ast
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
@en
P2093
P2860
P50
P1476
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients
@en
P2093
Agnes Jager
Annelieke S de Wit
Herman Burger
Ines Chaves
Jacqueline S L Kloth
Lisette Binkhorst
Paul Hamberg
Peter de Bruijn
Robbert J van Alphen
P2860
P2888
P304
P356
10.1007/S10549-015-3452-X
P407
P577
2015-06-07T00:00:00Z